Skip to content

Health Coaching Added to Standard Therapy for Hypertension: Blood Pressure and Quality of Life

The Effect of Health Coaching on Hypertension Management on Blood Pressure and Quality of Life of Patients in Primary Health Care Facilities

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07771504
Enrollment
98
Registered
2026-08-18
Start date
2025-07-28
Completion date
2025-11-12
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The goal of this clinical trial is to learn if adding health coaching to standard therapy lowers blood pressure and increases quality of life in adults with hypertension receiving care at a primary care clinic. The main questions it aims to answer are: Does adding health coaching to standard therapy lower systolic blood pressure? Does adding health coaching to standard therapy lower diastolic blood pressure? Does adding health coaching to standard therapy increase quality of life? Researchers will compare standard therapy plus health coaching with standard therapy alone to see if adding health coaching results in greater reductions in blood pressure and greater improvements in quality of life. articipants will: * Receive standard therapy for hypertension if assigned to the control group. * Receive standard therapy plus four health coaching sessions over 3 months if assigned to the intervention group. * Have their blood pressure measured before and after the study. * Complete a quality-of-life questionnaire at the beginning and end of the study.

Interventions

BEHAVIORALHealth Coaching

Four health coaching sessions delivered over 3 months in addition to standard therapy for hypertension.

OTHERStandard Therapy

Standard therapy for hypertension according to routine clinical care and the treating physician's clinical judgment.

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with hypertension at the study site aged \>18 years. * Patients diagnosed with hypertension within the previous 12 months. * Current participants of the Prolanis program at the study site. * Willing to participate in the study and provide written informed consent.

Exclusion criteria

* Patients with hypertension who are not registered as BPJS Kesehatan participants at the study FKTP. * Patients with hypertension who are already controlled with standard treatment. * Patients with hypertension with comorbidities (diabetes mellitus, stroke, or heart disease). * Patients with hypertension who smoke. * Patients with hypertension who have obesity.

Design outcomes

Primary

MeasureTime frameDescription
Change in Systolic Blood Pressure (SBP)From baseline to 3 monthsChange in systolic blood pressure from baseline to the end of the 3-month intervention period.
Change in Diastolic Blood Pressure (DBP)From baseline to 3 monthsChange in diastolic blood pressure from baseline to the end of the 3-month intervention period.
Change in Quality of Life Measured by WHOQOL-BREFFrom baseline to 3 monthsChange in quality of life from baseline to the end of the 3-month intervention period, assessed using the Indonesian version of the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire consisting of 26 items. Scores are transformed to a 0-100 scale, with higher scores indicating better quality of life.

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026